EstetrolEstetrol - High-quality laboratory reagent available from Gentaur. Catalog: 804-HY-15731-01.804-HY-15731-01804-HY-15731-01Business & Industrial > Science & LaboratoryEstetrol
Gentaur
EUR12027-02-19

Estetrol

CAT:
804-HY-15731-01
Size:
5 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Estetrol - image 1

Estetrol

  • Description:

    Estetrol, an orally active estrogen synthesized exclusively during pregnancy by the human fetal liver, is a selective nuclear estrogen receptor modulator. Estetrol binds ERα as well as ERβ (with a fourfold lower affinity) . Estetrol increases eNOS expression/activity and NO synthesis in endothelial cells. Estetrol exerts estrogenic actions on the endometrium or the central nervous system but presents antagonistic effects on the breast. Estetrol can be used in contraception and menopausal hormone research[1][2][3][4].
  • UNSPSC:

    12352005
  • Hazard Statement:

    H351, H360, H362
  • Target:

    Endogenous Metabolite; Estrogen Receptor/ERR; NO Synthase
  • Related Pathways:

    Immunology/Inflammation; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
  • Applications:

    Neuroscience-Neuromodulation
  • Field of Research:

    Cardiovascular Disease; Cancer
  • Purity:

    99.76
  • Solubility:

    DMSO : 100 mg/mL (ultrasonic)
  • Smiles:

    OC1=CC=C2C(CC[C@]3([H])[C@]2([H])CC[C@@]4(C)[C@@]3([H])[C@@H](O)[C@@H](O)[C@@H]4O)=C1
  • Molecular Formula:

    C18H24O4
  • Molecular Weight:

    304.39
  • Precautions:

    H351, H360, H362
  • References & Citations:

    [1]Valéra MC, et al. Effect of estetrol, a selective nuclear estrogen receptor modulator, in mouse models of arterial and venous thrombosis. Mol Cell Endocrinol. 2018 Dec 5;477:132-139.|[2]Montt-Guevara MM, et al. Estetrol Modulates Endothelial Nitric Oxide Synthesis in Human Endothelial Cells. Front Endocrinol (Lausanne) . 2015 Jul 22;6:111.|[3]Abot A, et al. The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activation. EMBO Mol Med. 2014 Oct;6 (10) :1328-46.|[4]Giretti MS, et al. Effects of Estetrol on Migration and Invasion in T47-D Breast Cancer Cells through the Actin Cytoskeleton. Front Endocrinol (Lausanne) . 2014 May 26;5:80.|[5]Coelingh Bennink HJ, et al. Ovulation inhibition by estetrol in an in vivo model. Contraception. 2008 Mar;77 (3) :186-90.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Scientific Category:

    Natural Products
  • Clinical Information:

    Launched
  • CAS Number:

    [15183-37-6]